Whole brain helical Tomotherapy with integrated boost for brain metastases in patients with malignant melanoma-a randomized trial

Radiation Oncology

Volumn 8, Issue 1, 2013, Pages

  Hauswald, Henrik ^a   Habl, Gregor ^a   Krug, David ^a   Kehle, Denise ^a   Combs, Stephanie E ^a   Bermejo, Justo L ^b   Debus, Jürgen ^a   Sterzing, Florian ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Brain metastases; Integrated boost; Malignant melanoma; Radiotherapy; Tomotherapy

Indexed keywords

ARTICLE; BRAIN METASTASIS; BRAIN RADIATION; CANCER RADIOTHERAPY; CANCER SURVIVAL; EXPLORATORY RESEARCH; HUMAN; MELANOMA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POST TREATMENT SURVIVAL; PROGRESSION FREE SURVIVAL; PROSPECTIVE STUDY; QUALITY OF LIFE; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RANDOMIZED CONTROLLED TRIAL (TOPIC); TOMOTHERAPY; TREATMENT RESPONSE; WHOLE BRAIN HELICAL TOMOTHERAPY; ADOLESCENT; ADULT; AGED; BRAIN NEOPLASMS; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED STUDY; FEMALE; INTENSITY MODULATED RADIATION THERAPY; MALE; METHODOLOGY; MIDDLE AGED; PROCEDURES; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; SECONDARY; SKULL IRRADIATION; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; CRANIAL IRRADIATION; DOSE FRACTIONATION; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; RESEARCH DESIGN; YOUNG ADULT;

EID: 84885163266     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-8-234     Document Type: Article

References (36)

1. Krebs in Deutschland 2007/2008. 8. Ausgabe Robert Koch-Institut (Hrsg) und die Gesellschaft der epidemiologischen Krebsregister in Deutschland e.V. (Hrsg). Berlin 2012, Krebs in Deutschland 2007/2008. 8. Ausgabe.
2. Fife KM, Colman MH, Stevens GN, Firth IC, Moon D, Shannon KF, Harman R, Petersen-Schaefer K, Zacest AC, Besser M, Milton GW, McCarthy WH, Thompson JF. Determinants of outcome in melanoma patients with cerebral metastases. J Clin Oncol 2004, 22:1293-1300. 10.1200/JCO.2004.08.140, 15051777.
3. Jemal A, Siegel R, Xu J, Ward E, Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010, 60:277-300. 10.3322/caac.20073, 20610543.
4. Amer MH, Al-Sarraf M, Baker LH, Vaitkevicius VK. Malignant melanoma and central nervous system metastases: incidence, diagnosis, treatment and survival. Cancer 1978, 42:660-668. 10.1002/1097-0142(197808)42:2<660::AID-CNCR2820420237>3.0.CO;2-E, 679158.
5. Patel JK, Didolkar MS, Pickren JW, Moore RH. Metastatic pattern of malignant melanoma. A study of 216 autopsy cases. Am J Surg 1978, 135:807-810. 10.1016/0002-9610(78)90171-X, 665907.
6. Bullard DE, Cox EB, Seigler HF. Central nervous system metastases in malignant melanoma. Neurosurgery 1981, 8:26-30. 10.1227/00006123-198101000-00006, 7207769.
7. Budman DR, Camacho E, Wittes RE. The current causes of death in patients with malignant melanoma. Eur J Cancer 1978, 14:327-330. 10.1016/0014-2964(78)90201-3, 648555.
8. Houghton A, Coit D, Bloomer W, Buzaid A, Chu D, Eisenburgh B, Guitart J, Johnson T, Miller S, Sener S, Tanabe K, Thompson J, Urist M, Walker M. NCCN melanoma practice guidelines. National comprehensive cancer network. Oncology (Williston Park) 1998, 12:153-177.
9. Sampson JH, Carter JH, Friedman AH, Seigler HF. Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma. J Neurosurg 1998, 88:11-20. 10.3171/jns.1998.88.1.0011, 9420067.
10. Samlowski WE, Watson GA, Wang M, Rao G, Klimo P, Boucher K, Shrieve DC, Jensen RL. Multimodality treatment of melanoma brain metastases incorporating stereotactic radiosurgery (SRS). Cancer 2007, 109:1855-1862. 10.1002/cncr.22605, 17351953.
11. Broadbent AM, Hruby G, Tin MM, Jackson M, Firth I. Survival following whole brain radiation treatment for cerebral metastases: an audit of 474 patients. Radiother Oncol 2004, 71:259-265. 10.1016/j.radonc.2004.02.019, 15172140.
12. Lagerwaard FJ, Levendag PC, Nowak PJ, Eijkenboom WM, Hanssens PE, Schmitz PI. Identification of prognostic factors in patients with brain metastases: a review of 1292 patients. Int J Radiat Oncol Biol Phys 1999, 43:795-803. 10.1016/S0360-3016(98)00442-8, 10098435.
13. Meier S, Baumert BG, Maier T, Wellis G, Burg G, Seifert B, Dummer R. Survival and prognostic factors in patients with brain metastases from malignant melanoma. Onkologie 2004, 27:145-149. 10.1159/000076903, 15138346.
14. Panagiotou IE, Brountzos EN, Kelekis DA, Papathanasiou MA, Bafaloukos DI. Cerebral metastases of malignant melanoma: contemporary treatment modalities and survival outcome. Neoplasma 2005, 52:150-158.
15. Rate WR, Solin LJ, Turrisi AT. Palliative radiotherapy for metastatic malignant melanoma: brain metastases, bone metastases, and spinal cord compression. Int J Radiat Oncol Biol Phys 1988, 15:859-864. 10.1016/0360-3016(88)90118-6, 2460420.
16. Choi KN, Withers HR, Rotman M. Intracranial metastases from melanoma. Clinical features and treatment by accelerated fractionation. Cancer 1985, 56:1-9. 10.1002/1097-0142(19850701)56:1<1::AID-CNCR2820560102>3.0.CO;2-X, 4005778.
17. Stevens G, Firth I, Coates A. Cerebral metastases from malignant melanoma. Radiother Oncol 1992, 23:185-191. 10.1016/0167-8140(92)90329-S, 1574597.
18. Ellerhorst J, Strom E, Nardone E, McCutcheon I. Whole brain irradiation for patients with metastatic melanoma: a review of 87 cases. Int J Radiat Oncol Biol Phys 2001, 49:93-97. 10.1016/S0360-3016(00)01355-9, 11163501.
19. Hauswald H, Dittmar J-O, Habermehl D, Rieken S, Sterzing F, Debus J, Combs SE. Efficacy and toxicity of whole brain radiotherapy in patients with multiple cerebral metastases from malignant melanoma. Radiat Oncol 2012, 7:130. 10.1186/1748-717X-7-130, 3444385, 22857154.
20. Buchsbaum JC, Suh JH, Lee S-Y, Chidel MA, Greskovich JF, Barnett GH. Survival by radiation therapy oncology group recursive partitioning analysis class and treatment modality in patients with brain metastases from malignant melanoma: a retrospective study. Cancer 2002, 94:2265-2272. 10.1002/cncr.10426, 12001126.
21. Gaspar L, Scott C, Rotman M, Asbell S, Phillips T, Wasserman T, McKenna WG, Byhardt R. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 1997, 37:745-751. 10.1016/S0360-3016(96)00619-0, 9128946.
22. Pirzkall A, Debus J, Lohr F, Fuss M, Rhein B, Engenhart-Cabillic R, Wannenmacher M. Radiosurgery alone or in combination with whole-brain radiotherapy for brain metastases. J Clin Oncol 1998, 16:3563-3569.
23. Kocher M, Soffietti R, Abacioglu U, Villà S, Fauchon F, Baumert BG, Fariselli L, Tzuk-Shina T, Kortmann R-D, Carrie C, Ben Hassel M, Kouri M, Valeinis E, van den Berge D, Collette S, Collette L, Mueller R-P. Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study. J Clin Oncol 2011, 29:134-141. 10.1200/JCO.2010.30.1655, 3058272, 21041710.
24. Seung SK, Sneed PK, McDermott MW, Shu HK, Leong SP, Chang S, Petti PL, Smith V, Verhey LJ, Wara WM, Phillips TL, Larson DA. Gamma knife radiosurgery for malignant melanoma brain metastases. Cancer J Sci Am 1998, 4:103-109.
25. Seung SK, Shu HK, McDermott MW, Sneed PK, Larson DA. Stereotactic radiosurgery for malignant melanoma to the brain. Surg Clin North Am 1996, 76:1399-1411. 10.1016/S0039-6109(05)70522-3, 8977558.
26. Grob JJ, Regis J, Laurans R, Delaunay M, Wolkenstein P, Paul K, Souteyrand P, Koeppel MC, Murraciole X, Perragut JC, Bonerandi JJ. Radiosurgery without whole brain radiotherapy in melanoma brain metastases. Club de Cancérologie Cutanée. Eur J Cancer 1998, 34:1187-1192. 10.1016/S0959-8049(98)00026-4, 9849477.
27. Herfarth KK, Izwekowa O, Thilmann C, Pirzkall A, Delorme S, Hofmann U, Schadendorf D, Zierhut D, Wannenmacher M, Debus J. Linac-based radiosurgery of cerebral melanoma metastases. Analysis of 122 metastases treated in 64 patients. Strahlenther Onkol 2003, 179:366-371.
28. Sterzing F, Welzel T, Sroka-Perez G, Schubert K, Debus J, Herfarth KK. Reirradiation of multiple brain metastases with helical tomotherapy. A multifocal simultaneous integrated boost for eight or more lesions. Strahlenther Onkol 2009, 185:89-93. 10.1007/s00066-009-1971-2, 19240994.
29. Marsh JC, Godbole RH, Herskovic AM, Gielda BT, Turian JV. Sparing of the neural stem cell compartment during whole-brain radiation therapy: a dosimetric study using helical tomotherapy. Int J Radiat Oncol Biol Phys 2010, 78:946-954. 10.1016/j.ijrobp.2009.12.012, 20472348.
30. Gondi V, Tolakanahalli R, Mehta MP, Tewatia D, Rowley H, Kuo JS, Khuntia D, Tomé WA. Hippocampal-sparing whole-brain radiotherapy: a " how-to" technique using helical tomotherapy and linear accelerator-based intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 2010, 78:1244-1252. 10.1016/j.ijrobp.2010.01.039, 2963699, 20598457.
31. Marks LB, Yorke ED, Jackson A, Ten Haken RK, Constine LS, Eisbruch A, Bentzen SM, Nam J, Deasy JO. Use of normal tissue complication probability models in the clinic. Int J Radiat Oncol Biol Phys 2010, 76:S10-S19. 10.1016/j.ijrobp.2009.07.1754, 20171502.
32. Flanigan JC, Jilaveanu LB, Chiang VL, Kluger HM. Advances in therapy for melanoma brain metastases. Clin Dermatol 2013, 31:264-281. 10.1016/j.clindermatol.2012.08.008, 23608446.
33. Awad R, Fogarty G, Hong A, Kelly P, Ng D, Santos D, Haydu L. Hippocampal avoidance with volumetric modulated arc therapy in melanoma brain metastases-the first Australian experience. Radiat Oncol 2013, 8:62. 10.1186/1748-717X-8-62, 3608934, 23497418.
34. Krause S, Beck S, Schramm O, Schubert K, Hauswald H, Zabel-du Bois A, Herfarth K, Debus J, Sterzing F. Tomotherapy radiosurgery for arteriovenous malformations-current possibilities and future options with helical tomotherapy dynamic jaws?. Technol Cancer Res Treat 2013, 12(5):421-428.
35. Sterzing F, Uhl M, Hauswald H, Schubert K, Sroka-Perez G, Chen Y, Lu W, Mackie R, Debus J, Herfarth K, Oliveira G. Dynamic jaws and dynamic couch in helical tomotherapy. Int J Radiat Oncol Biol Phys 2010, 76:1266-1273. 10.1016/j.ijrobp.2009.07.1686, 19910128.
36. Shaw E, Arusell R, Scheithauer B, O'Fallon J, O'Neill B, Dinapoli R, Nelson D, Earle J, Jones C, Cascino T, Nichols D, Ivnik R, Hellman R, Curran W, Abrams R. Prospective randomized trial of low- versus high-dose radiation therapy in adults with supratentorial low-grade glioma: initial report of a North central cancer treatment group/radiation therapy oncology group/eastern cooperative oncology group study. J Clin Oncol 2002, 20:2267-2276. 10.1200/JCO.2002.09.126, 11980997.